Progress in research on RAAS inhibitors regulating inflammatory responses and oxidative stress: from molecular mechanisms to clinical evidence
The renin-angiotensin-aldosterone system (RAAS) inhibitors serve as cornerstone pharmacotherapies for chronic conditions including hypertension, heart failure, and chronic kidney disease. Accumulating evidence over recent years has demonstrated that their target organ-protective effects cannot be fully attributed to bl...